Control of Methicillin-resistant Staphylococcus aureus

Infectious Disease Clinics of North America

Volumn 25, Issue 1, 2011, Pages 155-179

  Lee, Andie S ^a   Huttner, Benedikt ^a   Harbarth, Stephan ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Active surveillance; Decolonization; Epidemiology; Infection prevention; MRSA; Screening

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CHLORHEXIDINE; POVIDONE IODINE; PSEUDOMONIC ACID; SULFADIAZINE SILVER;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BLOODSTREAM INFECTION; DISEASE SURVEILLANCE; DISINFECTION; DRUG USE; ENVIRONMENTAL SANITATION; HAND WASHING; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; MASS SCREENING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PREVALENCE; PROTECTIVE CLOTHING; REVIEW;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 79551712482     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2010.11.002     Document Type: Review

References (115)

1. Styers D., Sheehan D.J., Hogan P., et al. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006, 5:2.
2. EARSS data Available at:, Accessed December 10, 2010. http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Pages/index.aspx.
3. Cosgrove S.E., Qi Y., Kaye K.S., et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26(2):166-174.
4. Marshall C., Wesselingh S., McDonald M., et al. Control of endemic MRSA-what is the evidence? A personal view. J Hosp Infect 2004, 56(4):253-268.
5. Dutch Working Party on Infection Prevention (WIP) Policy for methicillin-resistant Staphylococcus aureus Available at:, Accessed November 3, 2010. http://www.wip.nl/UK.
6. MacKenzie F.M., Bruce J., Struelens M.J., et al. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. Clin Microbiol Infect 2007, 13(3):269-276.
7. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355(7):666-674.
8. Vourli S., Vagiakou H., Ganteris G., et al. High rates of community-acquired, Panton-Valentine leukocidin (PVL)- positive methicillin-resistant S. aureus (MRSA) infections in adult outpatients in Greece. Euro Surveill 2009, 14(2):19089. pii.
9. van Belkum A., Melles D.C., Nouwen J., et al. Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 2009, 9(1):32-47.
10. Hidron A.I., Low C.E., Honig E.G., et al. Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis 2009, 9(6):384-392.
11. Seybold U., Kourbatova E.V., Johnson J.G., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006, 42(5):647-656.
12. Patel M., Waites K.B., Hoesley C.J., et al. Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies. J Hosp Infect 2008, 68(3):208-213.
13. Popovich K.J., Weinstein R.A., Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?. Clin Infect Dis 2008, 46(6):787-794.
14. D'Agata E.M., Webb G.F., Horn M.A., et al. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 2009, 48(3):274-284.
15. Chini V., Petinaki E., Meugnier H., et al. Emergence of a new clone carrying Panton-Valentine leukocidin genes and staphylococcal cassette chromosome mec type V among methicillin-resistant Staphylococcus aureus in Greece. Scand J Infect Dis 2008, 40(5):368-372.
16. Voss A., Loeffen F., Bakker J., et al. Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis 2005, 11(12):1965-1966.
17. Kock R., Harlizius J., Bressan N., et al. Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur J Clin Microbiol Infect Dis 2009, 28(11):1375-1382.
18. Shinefield H.R., Ruff N.L. Staphylococcal infections: a historical perspective. Infect Dis Clin North Am 2009, 23(1):1-15.
19. Chambers H.F., Deleo F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009, 7(9):629-641.
20. Hails J., Kwaku F., Wilson A.P., et al. Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis. Intensive Care Med 2003, 29(3):481-483.
21. Gastmeier P., Schwab F., Geffers C., et al. To isolate or not to isolate? Analysis of data from the German nosocomial infection surveillance system regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infect Control Hosp Epidemiol 2004, 25(2):109-113.
22. Sunenshine R.H., Liedtke L.A., Fridkin S.K., et al. Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States. Infect Control Hosp Epidemiol 2005, 26(2):138-143.
23. Jarvis W.R., Schlosser J., Chinn R.Y., et al. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control 2007, 35(10):631-637.
24. Carlet J., Astagneau P., Brun-Buisson C., et al. French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009, 30(8):737-745.
25. Liebowitz L.D. MRSA burden and interventions. Int J Antimicrob Agents 2009, 34(Suppl 3):S11-S13.
26. Available at: Accessed November 3, 2010. http://www.npsa.nhs.uk/cleanyourhands/.
27. National Health Service Clean, safe care: reducing MRSA and other healthcare associated infections Available at:, Accessed November 3, 2010. http://www.clean-safe-care.nhs.uk.
28. Stone S, Fuller C, Slade R, et al. The success and effectiveness of the world's first national clean your hands campaign in England and Wales 2004-2008: a prospective observational interrupted time-series [abstract O140]. Paper presented at the 19th European Congress of Clinical Microbiology and Infectious Diseases. Helsinki (Finland), May 16, 2009.
29. Kallen A.J., Mu Y., Bulens S., Reingold A., et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010, 304(6):641-648.
30. Burton D.C., Edwards J.R., Horan T.C., et al. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009, 301(7):727-736.
31. Climo M.W. Decreasing MRSA infections: an end met by unclear means. JAMA 2009, 301(7):772-773.
32. Humphreys H. Implementing guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: how valid are international comparisons of success?. J Hosp Infect 2006, 62(2):133-135.
33. Pittet D., Hugonnet S., Harbarth S., et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000, 356(9238):1307-1312.
34. Johnson P.D., Martin R., Burrell L.J., et al. Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust 2005, 183(10):509-514.
35. Grayson M.L., Jarvie L.J., Martin R., et al. Significant reductions in methicillin-resistant Staphylococcus aureus bacteraemia and clinical isolates associated with a multisite, hand hygiene culture-change program and subsequent successful statewide roll-out. Med J Aust 2008, 188(11):633-640.
36. World Health Organization (WHO) WHO guidelines on hand hygiene in health care. World alliance for patient safety 2009, WHO Press Geneva, Geneva (Switzerland).
37. Beggs C.B., Shepherd S.J., Kerr K.G. How does healthcare worker hand hygiene behaviour impact upon the transmission of MRSA between patients? an analysis using a Monte Carlo model. BMC Infect Dis 2009, 9:64.
38. Robicsek A., Beaumont J.L., Paule S.M., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008, 148(6):409-418.
39. Davis K.A., Stewart J.J., Crouch H.K., et al. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004, 39(6):776-782.
40. Albrich W.C., Harbarth S. Health-care workers: source, vector, or victim of MRSA?. Lancet Infect Dis 2008, 8(5):289-301.
41. Harbarth S., Masuet-Aumatell C., Schrenzel J., et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 2006, 10(1):R25.
42. Jernigan J.A., Titus M.G., Groschel D.H., et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996, 143(5):496-504.
43. Huang S.S., Yokoe D.S., Hinrichsen V.L., et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006, 43(8):971-978.
44. Chaberny I.F., Schwab F., Ziesing S., et al. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis. J Antimicrob Chemother 2008, 62(6):1422-1429.
45. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299(10):1149-1157.
46. Jeyaratnam D., Whitty C.J., Phillips K., et al. Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 2008, 336(7650):927-930.
47. Hardy K., Price C., Szczepura A., et al. Reduction in the rate of methicillin-resistant Staphylococcus aureus acquisition in surgical wards by rapid screening for colonization: a prospective, cross-over study. Clin Microbiol Infect 2010, 16(4):333-339.
48. McGinigle K.L., Gourlay M.L., Buchanan I.B. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis 2008, 46(11):1717-1725.
49. Tacconelli E., De Angelis G., de Waure C., et al. Rapid screening tests for methicillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 2009, 9(9):546-554.
50. Farr B.M., Jarvis W.R. Methicillin-resistant Staphylococcus aureus: misinterpretation and misrepresentation of active detection and isolation. Clin Infect Dis 2008, 47(9):1238-1239. [author reply: 1239-40].
51. Wagenvoort J.H., De Brauwer E.I., Gronenschild J.M., et al. Active surveillance cultures for methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2008, 47(9):1237-1238.
52. Dancer S.J. Considering the introduction of universal MRSA screening. J Hosp Infect 2008, 69(4):315-320.
53. Millar M. Should we screen low risk patients for methicillin resistant Staphylococcus aureus?. BMJ 2009, 339:b4035.
54. Edmond M.B., Ober J.F., Bearman G. Active surveillance cultures are not required to control MRSA infections in the critical care setting. Am J Infect Control 2008, 36(6):461-463.
55. Wenzel R.P., Bearman G., Edmond M.B. Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol 2008, 29(11):1012-1018.
56. Farr B.M., Jarvis W.R. Why we disagree with the analysis of Wenzel et al. Infect Control Hosp Epidemiol 2009, 30(5):497-499. author reply 499-500.
57. McCaughey B. Screening for methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2009, 30(9):927-928.
58. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003, 24(5):362-386.
59. Siegel J.D., Rhinehart E., Jackson M., Healthcare infection control practices advisory committee, et al. Management of multidrug resistant organisms in healthcare settings Available at:, Accessed November 3, 2010. http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf.
60. Strausbaugh L.J., Siegel J.D., Weinstein R.A. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin Infect Dis 2006, 42(6):828-835.
61. Muto C.A., Jarvis W.R., Farr B.M. Another tale of two guidelines. Clin Infect Dis 2006, 43(6):796-797. [author reply: 797-8].
62. Diekema D.J., Edmond M.B. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis 2007, 44(8):1101-1107.
63. Farr B.M., Jarvis W.R. Searching many guidelines for how best to control methicillin-resistant Staphylococcus aureus healthcare-associated spread and infection. Infect Control Hosp Epidemiol 2009, 30(8):808-809.
64. Calfee D.P., Salgado C.D., Classen D., et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S62-S80.
65. Weber S.G., Huang S.S., Oriola S., et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol 2007, 28(3):249-260.
66. Fraser V., Murphy D., Brennan P.J., et al. Politically incorrect: legislation must not mandate specific healthcare epidemiology and infection prevention and control practices. Infect Control Hosp Epidemiol 2007, 28(5):594-595.
67. Farr B.M. Political versus epidemiological correctness. Infect Control Hosp Epidemiol 2007, 28(5):589-593.
68. Klein B.S., Perloff W.H., Maki D.G. Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med 1989, 320(26):1714-1721.
69. Grant J., Ramman-Haddad L., Dendukuri N., et al. The role of gowns in preventing nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA): gown use in MRSA control. Infect Control Hosp Epidemiol 2006, 27(2):191-194.
70. Coia J.E., Duckworth G.J., Edwards D.I., et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006, 63(Suppl 1):S1-S44.
71. Bracco D., Dubois M.J., Bouali R., et al. Single rooms may help to prevent nosocomial bloodstream infection and cross-transmission of methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2007, 33(5):836-840.
72. Cepeda J.A., Whitehouse T., Cooper B., et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005, 365(9456):295-304.
73. Morgan D.J., Diekema D.J., Sepkowitz K., et al. Adverse outcomes associated with Contact Precautions: a review of the literature. Am J Infect Control 2009, 37(2):85-93.
74. Kirkland K.B. Taking off the gloves: toward a less dogmatic approach to the use of contact isolation. Clin Infect Dis 2009, 48(6):766-771.
75. Santos R.P., Mayo T.W., Siegel J.D. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations. Clin Infect Dis 2008, 47(1):110-116.
76. Kluytmans J., Struelens M. Methicillin resistant Staphylococcus aureus in the hospital. BMJ 2009, 338:b364.
77. Ammerlaan H.S., Kluytmans J.A., Wertheim H.F., et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009, 48(7):922-930.
78. Simor A.E., Daneman N. Staphylococcus aureus decolonization as a prevention strategy. Infect Dis Clin North Am 2009, 23(1):133-151.
79. Loveday H.P., Pellowe C.M., Jones S.R., et al. A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the joint MRSA working party (Subgroup A). J Hosp Infect 2006, 63(Suppl 1):S45-S70.
80. Loeb M., Main C., Walker-Dilks C., et al. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003, 4. CD003340.
81. Sandri A.M., Dalarosa M.G., Ruschel de Alcantara L., et al. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 2006, 27(2):185-187.
82. Ridenour G., Lampen R., Federspiel J., et al. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007, 28(10):1155-1161.
83. van Rijen M., Bonten M., Wenzel R., et al. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008, 4. CD006216.
84. Robicsek A., Beaumont J.L., Thomson R.B., et al. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009, 30(7):623-632.
85. Kluytmans J., Harbarth S. Methicillin-resistant Staphylococcus aureus decolonization: " yes, we can," but will it help?. Infect Control Hosp Epidemiol 2009, 30(7):633-635.
86. Upton A., Lang S., Heffernan H. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother 2003, 51(3):613-617.
87. Walker E.S., Levy F., Shorman M., et al. A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions. J Clin Microbiol 2004, 42(6):2792-2795.
88. Patel J.B., Gorwitz R.J., Jernigan J.A. Mupirocin resistance. Clin Infect Dis 2009, 49(6):935-941.
89. Simor A.E., Phillips E., McGeer A., et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44(2):178-185.
90. Mody L., Kauffman C.A., McNeil S.A., et al. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003, 37(11):1467-1474.
91. Milstone A.M., Passaretti C.L., Perl T.M. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008, 46(2):274-281.
92. Popovich K.J., Hota B., Hayes R., et al. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009, 30(10):959-963.
93. Climo M.W., Sepkowitz K.A., Zuccotti G., et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009, 37(6):1858-1865.
94. Batra R., Cooper B.S., Whiteley C., et al. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010, 50(2):210-217.
95. Dancer S.J. The effect of antibiotics on methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2008, 61(2):246-253.
96. Denis O., Jans B., Deplano A., et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. J Antimicrob Chemother 2009, 64(6):1299-1306.
97. Tacconelli E., De Angelis G., Cataldo M.A., et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008, 61(1):26-38.
98. Vernaz N., Sax H., Pittet D., et al. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 2008, 62(3):601-607.
99. Kaier K., Hagist C., Frank U., et al. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 2009, 30(4):346-353.
100. Harbarth S., Samore M.H. Interventions to control MRSA: high time for time-series analysis?. J Antimicrob Chemother 2008, 62(3):431-433.
101. Gould I.M. Comment on: Interventions to control MRSA: high time for time-series analysis?. J Antimicrob Chemother 2009, 63(1):224.
102. Charbonneau P., Parienti J.J., Thibon P., et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis 2006, 42(6):778-784.
103. Tacconelli E. Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Curr Opin Infect Dis 2009, 22(4):352-358.
104. Dellit T.H., Owens R.C., McGowan J.E., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44(2):159-177.
105. Sexton T., Clarke P., O'Neill E., et al. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect 2006, 62(2):187-194.
106. Chang S., Sethi A.K., Eckstein B.C., et al. Skin and environmental contamination with methicillin-resistant Staphylococcus aureus among carriers identified clinically versus through active surveillance. Clin Infect Dis 2009, 48(10):1423-1428.
107. Dancer S.J. Importance of the environment in methicillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 2008, 8(2):101-113.
108. Kramer A., Schwebke I., Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006, 6:130.
109. Bhalla A., Pultz N.J., Gries D.M., et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004, 25(2):164-167.
110. Huang S.S., Datta R., Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006, 166(18):1945-1951.
111. Goodman E.R., Platt R., Bass R., et al. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 2008, 29(7):593-599.
112. Dancer S.J., White L.F., Lamb J., et al. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med 2009, 7:28.
113. Humphreys H. Can we do better in controlling and preventing methicillin-resistant Staphylococcus aureus (MRSA) in the intensive care unit (ICU)?. Eur J Clin Microbiol Infect Dis 2008, 27(6):409-413.
114. Keshtgar M.R., Khalili A., Coen P.G., et al. Impact of rapid molecular screening for meticillin-resistant Staphylococcus aureus in surgical wards. Br J Surg 2008, 95(3):381-386.
115. Aldeyab M.A., Kearney M.P., Hughes C.M., et al. Can the use of a rapid polymerase chain screening method decrease the incidence of nosocomial methicillin-resistant Staphylococcus aureus?. J Hosp Infect 2009, 71(1):22-28.